Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Drospirenone + ethinylestradiol for bulimic behavior in women with bulimia nervosa
2011-006099-38Phase 2Active
- Sponsor
- Karolinska University Hospital
- Start
- Jun 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2 trial of drospirenone and ethinyl estradiol in bulimia nervosa (BN) and Eating Disorder Not Otherwise Specified (EDNOS) (2 arms), sponsored by Karolinska University Hospital. Primary endpoints: Change in bulimic behavior from baseline to the last month of treatment and Evaluation of eating disorders and psychiatric comorbidity. Started Jun 2012; status: active.
02
Drugs
drospirenoneethinyl estradiol
03
Conditions
bulimia nervosa (BN)Eating Disorder Not Otherwise Specified (EDNOS)
Beyond the preview
Go deeper on 2011-006099-38.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2011-006099-38.